# Predictive Oncology Inc. (POAI) Source: https://www.quantisnow.com/company/POAI Generated: 2026-11-10T05:25:39.862Z - Ticker: POAI - Exchange: NASDAQ - Sector: Health Care - Industry: Industrial Specialties - Website: predictive-oncology.com ## About Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Helomics, Soluble, and Skyline. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' exposure to infectious fluids collected during surgical and other patient procedures, as well as proprietary cleaning fluid and filters to users of its systems. The company also provides contract research organization (CRO) and AI-driven predictive models of tumor drug response to improve clinical outcomes to assist pharmaceutical, diagnostic, and biotech industries; and soluble and stable formulations for proteins, including vaccines, antibodies, and other protein therapeutics, as well as develops tumor models for precision cancer therapy and drug development. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence (AI) applied to diseases databases. The company sells its medical device products directly to hospitals and other medical facilities through employed sales representatives, independent contractors, and distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota. ## Latest POAI news and filings - 2025-12-12 22:24 UTC [SEC Form S-8] [SEC Form S-8 filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-predictive-oncology-inc-6314713) - 2025-12-12 22:17 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-leadership-update-regulation-6314681) - 2025-12-02 23:03 UTC [SEC Form 4] [Chief Executive Officer Vennare Raymond F covered exercise/tax liability with 2,373 shares, decreasing direct ownership by 27% to 6,418 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-vennare-raymond-f-covered-exercisetax-liability-with-6300329) - 2025-12-02 22:15 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-other-events-financial-6300174) - 2025-12-02 13:00 UTC [Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement](https://www.quantisnow.com/insight/predictive-oncology-regains-compliance-with-nasdaqs-minimum-stockholders-equity-requirement-6298836) - 2025-11-26 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-predictive-oncology-inc-6294385) - 2025-11-25 22:15 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-leadership-update-submission-6294002) - 2025-11-25 22:04 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-predictive-oncology-inc-6293958) - 2025-11-24 11:12 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-predictive-oncology-inc-6291326) - 2025-11-20 22:15 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-other-events-6289234) - 2025-11-20 22:00 UTC [SEC Form S-3] [Amendment: SEC Form S-3/A filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-3a-filed-by-predictive-oncology-inc-6289185) - 2025-11-17 13:00 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-regulation-fd-disclosure-6282185) - 2025-11-14 22:25 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-results-of-operations-6281481) - 2025-11-14 22:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-predictive-oncology-inc-6281424) - 2025-11-14 22:12 UTC [Earnings Date] [Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy](https://www.quantisnow.com/insight/predictive-oncology-reports-third-quarter-2025-financial-results-and-provides-6281394) - 2025-10-29 21:31 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-other-events-financial-6250517) - 2025-10-29 21:30 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-predictive-oncology-inc-6250516) - 2025-10-28 14:23 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-predictive-oncology-inc-6247418) - 2025-10-22 21:28 UTC [SEC Form S-3] [SEC Form S-3 filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-predictive-oncology-inc-6242129) - 2025-10-22 21:27 UTC [SEC Form S-3] [SEC Form S-3 filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-predictive-oncology-inc-6242128) - 2025-10-22 20:59 UTC [SEC Form D] [SEC Form D filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-predictive-oncology-inc-6242021) - 2025-10-22 20:56 UTC [SEC Form D] [SEC Form D filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-predictive-oncology-inc-6242007) - 2025-10-17 21:01 UTC [SEC Form 3] [SEC Form 3 filed by new insider Matthews Shawn](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-matthews-shawn-6237301) - 2025-10-17 21:01 UTC [SEC Form 3] [SEC Form 3 filed by new insider Mclaughlin Thomas Louis](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-mclaughlin-thomas-louis-6237293) - 2025-10-16 21:15 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Shareholder Director Nominations](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-shareholder-director-nominations-6236059) - 2025-10-16 14:15 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Predictive Oncology Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-predictive-oncology-inc-6235324) - 2025-10-14 12:00 UTC [Leadership Update] [Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy](https://www.quantisnow.com/insight/predictive-oncology-announces-additions-to-board-and-leadership-team-to-6231413) - 2025-10-08 16:05 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-regulation-fd-disclosure-6227434) - 2025-10-08 13:00 UTC [Public Offering] [Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy](https://www.quantisnow.com/insight/predictive-oncology-inc-announces-closing-of-3435-million-in-private-6227289) - 2025-09-29 22:32 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-entry-into-a-6215069) - 2025-09-29 13:47 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-regulation-fd-disclosure-6214110) - 2025-09-29 13:07 UTC [Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens](https://www.quantisnow.com/insight/predictive-oncology-inc-announces-private-placements-of-344-million-to-6214060) - 2025-09-25 12:05 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-material-modification-to-6211401) - 2025-09-25 12:00 UTC [Predictive Oncology Announces 1-for-15 Reverse Stock Split](https://www.quantisnow.com/insight/predictive-oncology-announces-1-for-15-reverse-stock-split-6211345) - 2025-09-12 21:01 UTC [SEC Form 8-K] [Predictive Oncology Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/predictive-oncology-inc-filed-sec-form-8-k-leadership-update-financial-6199692) - 2025-09-11 21:46 UTC [SEC Form 4] [Director Chung-Welch Nancy was granted 64,680 shares, increasing direct ownership by 335% to 83,993 units (SEC Form 4)](https://www.quantisnow.com/insight/director-chung-welch-nancy-was-granted-64680-shares-increasing-direct-ownership-6198449) - 2025-09-11 21:45 UTC [SEC Form 4] [Director Handley Daniel E was granted 64,680 shares, increasing direct ownership by 380% to 81,698 units (SEC Form 4)](https://www.quantisnow.com/insight/director-handley-daniel-e-was-granted-64680-shares-increasing-direct-6198447) - 2025-09-11 21:45 UTC [SEC Form 4] [Director Hawryluk Matthew was granted 64,680 shares, increasing direct ownership by 682% to 74,168 units (SEC Form 4)](https://www.quantisnow.com/insight/director-hawryluk-matthew-was-granted-64680-shares-increasing-direct-ownership-6198445) - 2025-09-11 21:44 UTC [SEC Form 4] [Director Rao Veena was granted 64,680 shares, increasing direct ownership by 709% to 73,797 units (SEC Form 4)](https://www.quantisnow.com/insight/director-rao-veena-was-granted-64680-shares-increasing-direct-ownership-6198443) - 2025-09-11 21:44 UTC [SEC Form 4] [Director St. Clair Gregory Sr was granted 64,680 shares, increasing direct ownership by 305% to 85,882 units (SEC Form 4)](https://www.quantisnow.com/insight/director-st-clair-gregory-sr-was-granted-64680-shares-increasing-6198442) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/POAI - Earnings history: https://www.quantisnow.com/earnings/POAI - Dividend history: https://www.quantisnow.com/dividends/POAI - Insider transactions: https://www.quantisnow.com/insiders/POAI - Options chain: https://www.quantisnow.com/options/POAI - SEC 8-K filings only: https://www.quantisnow.com/company/POAI/8-k - RSS and alerts for POAI: https://www.quantisnow.com/docs/rss-feeds.md